{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:03:55Z","timestamp":1771347835015,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Shandong Province of China","award":["ZR2023QH271"],"award-info":[{"award-number":["ZR2023QH271"]}]},{"name":"Natural Science Foundation of Shandong Province of China","award":["ZR2023QH241"],"award-info":[{"award-number":["ZR2023QH241"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370690"],"award-info":[{"award-number":["82370690"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taishan Scholars Program of Shandong Province","award":["tsqn201909199"],"award-info":[{"award-number":["tsqn201909199"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04633-w","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:18:20Z","timestamp":1771341500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics and clinical analysis reveal the potential diagnostic and prognostic role of DLD for pan cancer and renal carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Fengze","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"4633_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4633_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"4633_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"4633_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41392-023-01679-y","volume":"9","author":"B Chen","year":"2024","unstructured":"Chen B, Yu P, Chan WN, Xie F, Zhang Y, Liang L, Leung KT, Lo KW, Yu J, Tse GMK, Kang W, To KF. Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets. Signal Transduct Target Ther. 2024;9:6.","journal-title":"Signal Transduct Target Ther"},{"key":"4633_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34.","journal-title":"J Hematol Oncol"},{"key":"4633_CR6","doi-asserted-by":"crossref","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, Eaton JK, Frenkel E, Kocak M, Corsello SM, Lutsenko S, Kanarek N, Santagata S, Golub TR. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","DOI":"10.1126\/science.abf0529"},{"key":"4633_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jmedgenet-2015-103334","volume":"52","author":"X Qi","year":"2015","unstructured":"Kahlson MA, Dixon SJ. Copper-induced cell death. Science. 2022;375:1231\u20132.","journal-title":"J Med Genet"},{"key":"4633_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Mattevi A, Schierbeek AJ, Hol WG. Refined crystal structure of lipoamide dehydrogenase from azotobacter vinelandii at 2.2 A resolution. A comparison with the structure of glutathione reductase. J Mol Biol. 1991;220:975\u201394.","journal-title":"Science"},{"key":"4633_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.abo3959","volume":"375","author":"MA Kahlson","year":"2022","unstructured":"Lei G, Tang L, Yu Y, Bian W, Yu L, Zhou J, Li Y, Wang Y, Du J. The potential of targeting Cuproptosis in the treatment of kidney renal clear cell carcinoma. Biomed Pharmacother. 2023;167:115522.","journal-title":"Science"},{"key":"4633_CR10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/0022-2836(91)90367-F","volume":"220","author":"A Mattevi","year":"1991","unstructured":"Santoni M, Buti S, Myint ZW, Maruzzo M, Iacovelli R, Pichler M, Kopecky J, Kucharz J, Rizzo M, Galli L, B\u00fcttner T, De Giorgi U, Kanesvaran R, Fiala O, Grande E, Zucali PA, Kopp RM, Fornarini G, Bourlon MT, Scagliarini S, Molina-Cerrillo J, Aurilio G, Matrana MR, Pichler R, Cattrini C, B\u00fcchler T, Massari F, Seront E, Calabr\u00f2 F, Pinto A, Berardi R, Zgura A, Mammone G, Ansari J, Atzori F, Chiari R, Bamias A, Caffo O, Procopio G, Sunela K, Bassanelli M, Ortega C, Grillone F, Landmesser J, Milella M, Messina C, K\u00fcronya Z, Mosca A, Bhuva D, Santini D, Vau N, Morelli F, Incorvaia L, Rebuzzi SE, Roviello G, Soares A, Bisonni R, Bimbatti D, Zabalza IO, Rizzo A, Mollica V, Sorgentoni G, Monteiro FSM, Battelli N, Bracarda S, Porta C. Real-world outcome of patients with advanced renal cell carcinoma and Intermediate- or Poor-risk international metastatic renal cell carcinoma database consortium criteria treated by Immune-oncology combinations: Differential Effectiveness by Risk Group? Eur Urol Oncol. 2024. 7: 102\u2009\u2013\u200911.","journal-title":"J Mol Biol"},{"key":"4633_CR11","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.biopha.2023.115522","volume":"167","author":"G Lei","year":"2023","unstructured":"Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, Wernerus H, Bj\u00f6rling L, Ponten F. Towards a knowledge-based human protein atlas. Nat Biotechnol. 2010;28:1248\u201350.","journal-title":"Biomed Pharmacother"},{"key":"4633_CR12","doi-asserted-by":"crossref","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pont\u00e9n F. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","DOI":"10.1126\/science.1260419"},{"key":"4633_CR13","doi-asserted-by":"crossref","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A web server for comprehensive analysis of Tumor-Infiltrating immune cells. Cancer Res. 2017;77:e108\u201310.","DOI":"10.1158\/0008-5472.CAN-17-0307"},{"key":"4633_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11523-021-00861-y","volume":"17","author":"V Mollica","year":"2022","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, Pfeil J, Narkizian J, Deran AD, Musselman-Brown A, Schmidt H, Amstutz P, Craft B, Goldman M, Rosenbloom K, Cline M, O\u2019Connor B, Hanna M, Birger C, Kent WJ, Patterson DA, Joseph AD, Zhu J, Zaranek S, Getz G, Haussler D, Paten B. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35:314\u20136.","journal-title":"Target Oncol"},{"key":"4633_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41585-022-00676-0","volume":"20","author":"M Rosellini","year":"2023","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nat Rev Urol"},{"key":"4633_CR16","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.2217\/fon-2021-0069","volume":"17","author":"A Rizzo","year":"2021","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, Creighton CJ, Varambally S. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Future Oncol"},{"key":"4633_CR17","first-page":"624","volume":"31","author":"DC Guven","year":"2023","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, Chu KC, Wong CY, Lau CY, Chen I, Chan NW, Zhang J. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35:4200\u20132.","journal-title":"Support Care Cancer"},{"key":"4633_CR18","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","volume":"17","author":"A Rizzo","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, Jensen LJ, von Mering C. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u201312.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4633_CR19","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","volume":"28","author":"M Uhlen","year":"2010","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Biotechnol"},{"key":"4633_CR20","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Science"},{"key":"4633_CR21","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"H\u00e4nzelmann S, Castelo R, & Guinney J (2013). GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 14, 7.","journal-title":"Cancer Res"},{"key":"4633_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, Xu L, Luo T, Yan H, Long Z, Shi A, Zhao T, Xiao Y, Li X. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47:D900\u20138.","journal-title":"Nat Biotechnol"},{"key":"4633_CR23","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649\u201358.","journal-title":"Nucleic Acids Res"},{"key":"4633_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Koch A, Jeschke J, Van Criekinge W, van Engeland M, De Meyer T. MEXPRESS update 2019. Nucleic Acids Res. 2019;47:W561\u20135.","journal-title":"Neoplasia"},{"key":"4633_CR25","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Bioinformatics"},{"key":"4633_CR26","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27:450\u201361.","journal-title":"Nucleic Acids Res"},{"key":"4633_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Chen H, Yang M, Wang Q, Song F, Li X, Chen K. The new identified biomarkers determine sensitivity to immune check-point Blockade therapies in melanoma. Oncoimmunology. 2019;8:1608132.","journal-title":"Nat Genet"},{"key":"4633_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, Kapralov AA, Amoscato AA, Jiang J, Anthonymuthu T, Mohammadyani D, Yang Q, Proneth B, Klein-Seetharaman J, Watkins S, Bahar I, Greenberger J, Mallampalli RK, Stockwell BR, Tyurina YY, Conrad M, Bay\u0131r H. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nucleic Acids Res"},{"key":"4633_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"Shimada K, Reznik E, Stokes ME, Krishnamoorthy L, Bos PH, Song Y, Quartararo CE, Pagano NC, Carpizo DR, deCarvalho AC, Lo DC, Stockwell BR. Copper-Binding small molecule induces oxidative stress and cell-cycle arrest in glioblastoma-patient-derived cells. Cell Chem Biol. 2018. 25, 585\u2009\u2013\u200994.e7.","journal-title":"BMC Bioinformatics"},{"key":"4633_CR30","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yip NC, Fombon IS, Liu P, Brown S, Kannappan V, Armesilla AL, Xu B, Cassidy J, Darling JL, Wang W. Disulfiram modulated ROS-MAPK and NF\u03baB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br J Cancer. 2011;104:1564\u201374.","journal-title":"Nucleic Acids Res"},{"key":"4633_CR31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chen D, Cui QC, Yang H, Dou QP. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via Inhibition of the proteasome activity. Cancer Res. 2006;66:10425\u201333.","journal-title":"Neoplasia"},{"key":"4633_CR32","doi-asserted-by":"publisher","first-page":"W561","DOI":"10.1093\/nar\/gkz445","volume":"47","author":"A Koch","year":"2019","unstructured":"Tsvetkov P, Detappe A, Cai K, Keys HR, Brune Z, Ying W, Thiru P, Reidy M, Kugener G, Rossen J, Kocak M, Kory N, Tsherniak A, Santagata S, Whitesell L, Ghobrial IM, Markley JL, Lindquist S, Golub TR. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15:681\u20139.","journal-title":"Nucleic Acids Res"},{"key":"4633_CR33","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Blackman RK, Cheung-Ong K, Gebbia M, Proia DA, He S, Kepros J, Jonneaux A, Marchetti P, Kluza J, Rao PE, Wada Y, Giaever G, Nislow C. Mitochondrial electron transport is the cellular target of the oncology drug elesclomol. PLoS ONE. 2012;7:e29798.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4633_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Yumnam S, Kang MC, Oh SH, Kwon HC, Kim JC, Jung ES, Lee CH, Lee AY, Hwang JI, Kim SY. Downregulation of dihydrolipoyl dehydrogenase by UVA suppresses melanoma progression via triggering oxidative stress and altering energy metabolism. Free Radic Biol Med. 2021;162:77\u201387.","journal-title":"Cancer Cell"},{"key":"4633_CR35","doi-asserted-by":"publisher","first-page":"1608132","DOI":"10.1080\/2162402X.2019.1608132","volume":"8","author":"H Chen","year":"2019","unstructured":"Shin D, Lee J, You JH, Kim D, Roh JL. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer. Redox Biol. 2020;30:101418.","journal-title":"Oncoimmunology"},{"key":"4633_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Sack LM, Davoli T, Li MZ, Li Y, Xu Q, Naxerova K, Wooten EC, Bernardi RJ, Martin TD, Chen T, Leng Y, Liang AC, Scorsone KA, Westbrook TF, Wong KK, Elledge SJ. Profound tissue specificity in proliferation control underlies cancer drivers and aneuploidy patterns. Cell. 2018;173:499\u2013e51423.","journal-title":"Nat Chem Biol"},{"key":"4633_CR37","doi-asserted-by":"crossref","unstructured":"Rich V. Chernobyl accident. Reactor design not perfect. Nature. 1986;322:588.","DOI":"10.1038\/322588a0"},{"key":"4633_CR38","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/bjc.2011.126","volume":"104","author":"NC Yip","year":"2011","unstructured":"Santoni M, Massari F, Myint ZW, Iacovelli R, Pichler M, Basso U, Kopecky J, Kucharz J, Buti S, Rizzo M, Galli L, B\u00fcttner T, De Giorgi U, Kanesvaran R, Fiala O, Grande E, Zucali PA, Fornarini G, Bourlon MT, Scagliarini S, Molina-Cerrillo J, Aurilio G, Matrana MR, Pichler R, Cattrini C, B\u00fcchler T, Seront E, Calabr\u00f2 F, Pinto A, Berardi R, Zgura A, Mammone G, Ansari J, Atzori F, Chiari R, Bamias A, Caffo O, Procopio G, Bassanelli M, Merler S, Messina C, K\u00fcronya Z, Mosca A, Bhuva D, Vau N, Incorvaia L, Rebuzzi SE, Roviello G, Zabalza IO, Rizzo A, Mollica V, Sorgentoni G, Monteiro FSM, Montironi R, Battelli N, Porta C. Global Real-World outcomes of patients receiving Immuno-Oncology combinations for advanced renal cell carcinoma: the ARON-1 study. Target Oncol. 2023. 18: 559\u2009\u2013\u200970.","journal-title":"Br J Cancer"},{"key":"4633_CR39","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","volume":"66","author":"D Chen","year":"2006","unstructured":"Santoni M, Massari F, Bracarda S, Grande E, Matrana MR, Rizzo M, De Giorgi U, Basso U, Aurilio G, Incorvaia L, Martignetti A, Molina-Cerrillo J, Mollica V, Rizzo A, Battelli N. Cabozantinib in patients with advanced renal cell carcinoma primary refractory to First-line immunocombinations or tyrosine kinase inhibitors. Eur Urol Focus. 2022;8:1696\u2013702.","journal-title":"Cancer Res"},{"key":"4633_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12011-016-0768-2","volume":"175","author":"AK Baltaci","year":"2017","unstructured":"Dhuli K, Micheletti C, Medori MC, Maltese PE, Tanzi B, Tezzele S, Mareso C, Generali D, Donofrio CA, Cominetti M, Fioravanti A, Riccio L, Beccari T, Ceccarini MR, Stuppia L, Gatta V, Cristoni S, Cecchin S, Marceddu G, Bertelli M. Omics sciences and precision medicine in kidney cancer. Clin Ter. 2023;174:46\u201354.","journal-title":"Biol Trace Elem Res"},{"key":"4633_CR41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/carcin\/bgx051","volume":"38","author":"M Stepien","year":"2017","unstructured":"Weil AR. Precision Medicine. Health Aff. 37, 687. 2018.","journal-title":"Carcinogenesis"},{"key":"4633_CR42","doi-asserted-by":"publisher","first-page":"106092","DOI":"10.1016\/j.ejps.2021.106092","volume":"169","author":"MC Ruiz","year":"2022","unstructured":"Rosellini M, Marchetti A, Mollica V, Rizzo A, Santoni M, Massari F. Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma. Nat Rev Urol. 2023;20:133\u201357.","journal-title":"Eur J Pharm Sci"},{"key":"4633_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Morgan AE, Davies TJ, Mc Auley MT. The role of DNA methylation in ageing and cancer. Proc Nutr Soc. 2018;77:412\u201322.","journal-title":"Nat Chem Biol"},{"key":"4633_CR44","doi-asserted-by":"publisher","first-page":"e29798","DOI":"10.1371\/journal.pone.0029798","volume":"7","author":"RK Blackman","year":"2012","unstructured":"Timar J, Kashofer K. Molecular epidemiology and diagnostics of KRAS mutations in human cancer. Cancer Metastasis Rev. 2020;39:1029\u201338.","journal-title":"PLoS ONE"},{"key":"4633_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.freeradbiomed.2020.11.037","volume":"162","author":"S Yumnam","year":"2021","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150:12\u201327.","journal-title":"Free Radic Biol Med"},{"key":"4633_CR46","doi-asserted-by":"publisher","first-page":"101418","DOI":"10.1016\/j.redox.2019.101418","volume":"30","author":"D Shin","year":"2020","unstructured":"Zhang W, Chen P, Li Z, Zhang R, Zhang J. Clinical implication of Keratin-15 quantification for renal cell carcinoma management: its dysregulation and association with clinicopathologic characteristics and prognostication. Tohoku J Exp Med. 2023;260:99\u2013107.","journal-title":"Redox Biol"},{"key":"4633_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cell.2018.02.037","volume":"173","author":"LM Sack","year":"2018","unstructured":"Tan HS, Jiang WH, He Y, Wang DS, Wu ZJ, Wu DS, Gao L, Bao Y, Shi JZ, Liu B, Ma LJ, Wang LH. KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma. Oncotarget. 2017;8:76189\u2013203.","journal-title":"Cell"},{"key":"4633_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1017\/S0029665118000150","volume":"77","author":"AE Morgan","year":"2018","unstructured":"Bourdon E, Swierczewski T, Goujon M, Boukrout N, Fellah S, Van der Hauwaert C, Larrue R, Lefebvre B, Van Seuningen I, Cauffiez C, Pottier N, Perrais M. MUC1 drives the progression and chemoresistance of clear cell renal carcinomas. Cancers. 2024. 16: 391","journal-title":"Proc Nutr Soc"},{"key":"4633_CR49","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10555-020-09915-5","volume":"39","author":"J Timar","year":"2020","unstructured":"He J, Yang B. Aquaporins in renal diseases. Int J Mol Sci 20. 2019.","journal-title":"Cancer Metastasis Rev"},{"key":"4633_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Tan SK, Hougen HY, Merchan JR, Gonzalgo ML, Welford SM. Fatty acid metabolism reprogramming in ccrcc: mechanisms and potential targets. Nat Rev Urol. 2023;20:48\u201360.","journal-title":"Cell"},{"key":"4633_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/322588a0","volume":"322","author":"V Rich","year":"1986","unstructured":"Du W, Zhang L, Brett-Morris A, Aguila B, Kerner J, Hoppel CL, Puchowicz M, Serra D, Herrero L, Rini BI, Campbell S, Welford SM. HIF drives lipid deposition and cancer in CcRCC via repression of fatty acid metabolism. Nat Commun. 2017;8:1769.","journal-title":"Nature"},{"key":"4633_CR52","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.euf.2022.02.004","volume":"8","author":"M Santoni","year":"2022","unstructured":"Peng S, Wang Z, Tang P, Wang S, Huang Y, Xie Q, Wang Y, Tan X, Tang T, Yan X, Xu J, Lan W, Wang L, Zhang D, Wang B, Pan T, Qin J, Jiang J, Liu Q. PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma. Sci Adv. 2023;9:eadf3566.","journal-title":"Eur Urol Focus"},{"key":"4633_CR53","first-page":"46","volume":"174","author":"K Dhuli","year":"2023","unstructured":"Smart MC, Dedoussis G, Louizou E, Yannakoulia M, Drenos F, Papoutsakis C, Maniatis N, Humphries SE, Talmud PJ. APOE, CETP and LPL genes show strong association with lipid levels in Greek children. Nutr Metab Cardiovasc Dis. 2010;20:26\u201333.","journal-title":"Clin Ter"},{"key":"4633_CR54","doi-asserted-by":"crossref","unstructured":"Klatte T, Rossi SH, Stewart GD. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J Urol. 2018;36:1943\u201352.","DOI":"10.1007\/s00345-018-2309-4"},{"key":"4633_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1620\/tjem.2023.J017","volume":"260","author":"W Zhang","year":"2023","unstructured":"Ficarra V, Galfano A, Mancini M, Martignoni G, Artibani W. TNM staging system for renal-cell carcinoma: current status and future perspectives. Lancet Oncol. 2007;8:554\u20138.","journal-title":"Tohoku J Exp Med"},{"key":"4633_CR56","doi-asserted-by":"publisher","first-page":"76189","DOI":"10.18632\/oncotarget.19198","volume":"8","author":"HS Tan","year":"2017","unstructured":"Delahunt B, Eble JN, Egevad L, Samaratunga H. Grading of renal cell carcinoma. Histopathology. 2019;74:4\u201317.","journal-title":"Oncotarget"},{"key":"4633_CR57","doi-asserted-by":"crossref","unstructured":"Gui CP, Chen YH, Zhao HW, Cao JZ, Liu TJ, Xiong SW, Yu YF, Liao B, Cao Y, Li JY, Huang KB, Han H, Zhang ZL, Chen WF, Jiang ZY, Gao Y, Han GP, Tang Q, Ouyang K, Qu GM, Wu JT, Guo JP, Li CX, Li PX, Liu ZP, Hsieh JT, Cai MY, Li XS, Wei JH, Luo JH. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study. Lancet Digit Health. 2023;5:e515\u201324.","DOI":"10.1016\/S2589-7500(23)00095-X"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04633-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04633-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04633-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:04:14Z","timestamp":1771344254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04633-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4633"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04633-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in strict alignment with the ethical principles and guidelines of the Declaration of Helsinki. The Ethics Committee of the Yantaiyuhuangding Hospital granted approval for this research (Ethical Number: 2024\u2009\u2212\u2009137). The study obtained written informed consent from all patients for their participation. The authors affirm that human research participants provided formal informed consent for participation of the images in Figures and Tables.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}